Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

JCI Editorial Board
potential first-tier conflicts of interest

Updated February 17, 2023

Go to the JCI's conflict-of-interest policy

 

AbbVie (A.B. Heimberger)

AccureX (D. Krainc)

Alnylam (A.B. Heimberger)

Aplexis Inc. (P. Ji)

Arvinas (M. Hussain)

AstraZeneca (M. Hussain)

Bayer (M. Hussain)

BioMed Central (H. Perlman)

Boehringer Ingelheim (G.D. Barish)

Calidi Biotherapeutics (M.S. Lesniak)

Caris Life Sciences (A.B. Heimberger)

Cell IDx (E.M. McNally)

Celularity (A.B. Heimberger)

Cytokinetics (E.M. McNally)

Ethicon, Johnson & Johnson (J. Pandolfino)

Genentech (M. Hussain)

Ikaika Therapeutics Inc. (E.M. McNally)

Inomagen Therapeutics (R. Arora)

Intellia Therapeutics (D. Krainc)

Ionis (J. Bass)

Ironwood (J. Pandolfino)

Lakeside Discovery (E.M. McNally)

Leal Therapeutics (D. Krainc)

Leducq Foundation (H. Ardehali)

Lung Healing Technologies (A. Bharat)

Mannin Research Inc. (S.E. Quaggin)

Medtronic (J. Bass, J. Pandolfino)

Michael J. Fox Foundation (D. Krainc)

Neurocrine Biosciences (A.L. George Jr.)

Nfold (S. Eisenbarth)

OrbiMed Advisors (D. Krainc)

PepGen (E.M. McNally)

Pfizer (N.S. Chandel, E.M. McNally)

Praxis Precision Medicines (A.L. George Jr.)

Rafael Pharmaceuticals (N.S. Chandel)

Regeneron (J. Bass)

Tenaya Therapeutics (E.M. McNally)

Tevard Biosciences (A.L. George Jr.)

Thermo Fisher Scientific (J. Bass)

Vanqua Bio (D. Krainc)

Vertex Pharmaceuticals (J. Bass)

Vortex Therapeutics (S.A. Abdulkadir)

WCG Oncology (A.B. Heimberger)

Zoe Biosciences (D.E. Vaughan)

Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts